Biomedical literature, made navigable

Follow the entities shaping the evidence.

Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.

An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.

View all families

Organisations named as supporting, sponsoring, or funding research.

5,089 articles · 9,137 mentions Institutions

Universities, hospitals, research centres, networks, and public bodies.

11,350 articles · 22,378 mentions Drugs

Named medicines, compounds, vaccines, and pharmacological agents.

10,506 articles · 58,393 mentions Diseases

Named diseases, disorders, syndromes, injuries, and health conditions.

23,712 articles · 125,551 mentions Treatments

Clinical therapies and care approaches used to manage a condition.

7,227 articles · 16,644 mentions Interventions

Programmes, procedures, policies, and other actions being evaluated.

4,132 articles · 9,994 mentions Clinical instruments

Named questionnaires, scales, scores, indices, and other clinical outcome assessments.

945 articles · 1,957 mentions

29,499matching articles

244,054matching entity mentions

30popular entities listed

0%of mentions human-reviewed

Filter articles

Entity familyJournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

Matching articles

29,499 articles · page 260 of 2459

IDDF2026-ABS-0143 CD44-targeted phage-mediated photodynamic therapy induces multi-modal cell death to overcome chemoresistance in colorectal cancer

gutjnl · abstract · 2026-06-26 · 15 matching annotations

96.8%

CRC colorectal cancer A6-Sp-TVP A6-Sp-TVP-PDT

…system enables specific photosensitizer enrichment in CD44-high CRC cells. A6-Sp-TVP-PDT expands cell death from single apoptosis t…

IDDF2026-ABS-0156 Does measuring the components of the fibrosis-4 index (FIB-4) separately on different days affect its performance in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)?

gutjnl · abstract · 2026-06-26 · 15 matching annotations

98.6%

MASLD FIB-4 Veterans Health Administration

…stribution hazard model.Results 2,236 and 561,012 patients with MASLD were included in the HK CDARS cohort and the VHA cohort. In the…

IDDF2026-ABS-0238 Early paracentesis and mortality in cirrhosis without encephalopathy or renal dysfunction - a causal analysis

gutjnl · abstract · 2026-06-26 · 15 matching annotations

97.5%

decompensated cirrhosis paracentesis hepatic encephalopathy 2022 National Readmissions Database ascites early paracentesis

…issions Database. We identified 41,254 hospitalized adults with decompensated cirrhosis who underwent paracentesis. We used double machine learning (DM…

IDDF2026-ABS-0239 Obesity and recurrent C.diff link: a large-scale study of hospitalized IBD patients

gutjnl · abstract · 2026-06-26 · 15 matching annotations

87.5%

IBD inflammatory bowel disease rCDI ulcerative colitis

…ar null findings for obesity.Conclusions In this large national IBD inpatient cohort, obesity was not associated with increased rCD…

IDDF2026-ABS-0244 MQU10 psychobiotic reduces depressive symptoms: pilot trial and preclinical evidence

gutjnl · abstract · 2026-06-26 · 15 matching annotations

99.0%

Generalized Anxiety Disorder-7 Patient Health Questionnaire-9 MQU10 depression neuropsychiatric disorders depression-like InnoHK ClinicalTrials.gov Chinese Clinical Trial Registry Generalised Anxiety Disorder-7

… scale at week 6. Secondary outcomes included changes in PHQ-9, Generalised Anxiety Disorder-7 (GAD-7), World Health Organisation Quality of Life-Brief Versio…

IDDF2026-ABS-0267 The mucosa remembers: is endoscopic remission in IBD a molecular dead end?

gutjnl · abstract · 2026-06-26 · 15 matching annotations

98.3%

IBD IBD-context

…erentially expressed genes).Conclusions Endoscopic remission in IBD does not restore normal mucosal gene expression. Fibrotic progr…

IDDF2026-ABS-0491 Endoscopic biliopancreatic stent placement combined with enucleation for pancreatic head cystic adenoma: a retrospective analysis

gutjnl · abstract · 2026-06-26 · 15 matching annotations

99.5%

pancreatic head cystic adenomas En biliopancreatic duct stricture pancreatic duct stricture

…tic duct stricture was reported in the En group.Conclusions For pancreatic head cystic adenomas, preoperative endoscopic biliopancreatic duct stent placement c…

IDDF2026-ABS-0514 Vonoprazan–amoxicillin dual therapy with or without saccharomyces boulardii supplementation as a rescue regimen for helicobacter pylori infection running title: rescue regimen for helicobacter pylori infection

gutjnl · abstract · 2026-06-26 · 15 matching annotations

95.8%

H. pylori Helicobacter pylori amoxicillin S. boulardii vonoprazan furazolidone VA

…e-center, randomized controlled trial, 190 adults with previous H. pylori treatment failure were assigned to receive either vonoprazan (2…

IDDF2026-ABS-0543 Efficacy and safety of upadacitinib in difficult-to-treat inflammatory bowel disease: a prospective, multicenter, real-world study (easeupibd study)

gutjnl · abstract · 2026-06-26 · 15 matching annotations

98.5%

Upadacitinib ulcerative colitis Crohn’s disease DTT-IBD UC inflammatory bowel disease

…t-to-treat inflammatory bowel disease (DTT-IBD) is challenging. Upadacitinib, an oral Janus kinase 1 inhibitor, has demonstrated efficacy in…

FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer

jitc · abstract · 2026-06-25 · 15 matching annotations

95.2%

Non-small cell lung cancer NSCLC FLT3L TCGA FLT3L-cDC1 ISV FLT3L-cDC1

…Background Non-small cell lung cancer (NSCLC) frequently evades immune surveillance through defective…

GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee osteoarthritis: a scoping review

bjsports · abstract · 2026-06-25 · 15 matching annotations

96.4%

Joanna Briggs Institute GLP-1-RAs Arksey and O’Malley glucagon-like peptide-1 receptor agonists obesity OA hip OA

…ews (PRISMA-ScR) framework and methodological guidance from the Joanna Briggs Institute and Arksey and O’Malley.Data sources PubMed, Web of Science, Di…

Preparing for systematic tuberculosis screening of children and young people in a low-incidence setting: who should we target?

archdischild · abstract · 2026-06-25 · 15 matching annotations

96.2%

TB NHSGGC tuberculosis TB-endemic NHS Greater Glasgow and Clyde CYPSAR-U

…ess urgent action is taken.2 In Scotland, no systematic migrant TB screening programme exists, with screening either opportunistic…